๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Epidermal growth factor in urine from patients with bladder cancer

โœ Scribed by Ohmori, H. ;Saika, T. ;Kumon, H. ;Tsushima, T. ;Nasu, Y.

Publisher
Springer
Year
2000
Tongue
English
Weight
102 KB
Volume
28
Category
Article
ISSN
0300-5623

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Epidermal growth factorโ€“related transfor
Epidermal growth factorโ€“related transforming growth factors in the urine of patients with hepatocellular carcinoma
โœ Ph.D. Lea-Yea Chuang; Juei-Hsiung Tsai; Yun-Chi Yeh; Chun-Chang Chang; Hsing-Wu ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 472 KB

To characterize epidermal growth factor-related transforming growth factors in the urine of patients with hepatocellular carcinoma, gel filtration with Bio-Gel P-30 was performed in seven hepatocellular carcinoma patients and seven sex-matched and agematched healthy controls. Distinct profiles of so

Detection of circulating cancer cells ex
Detection of circulating cancer cells expressing uroplakins and epidermal growth factor receptor in bladder cancer patients
โœ Iman Osman; Melissa Kang; Andy Lee; Fang-Ming Deng; David Polsky; Maryann Mikhai ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 141 KB ๐Ÿ‘ 1 views

## Abstract Our purpose was to determine the clinical relevance of the detection of circulating tumor cells (CTCs) expressing urothelial and epithelial markers in bladder cancer patients. Sixtyโ€two patients who presented to Memorial Sloanโ€Kettering Cancer Center between July 2000 and September 2001

Expression of epidermal growth factor re
Expression of epidermal growth factor receptor in urinary bladder cancer metastases
โœ Peter Bue; Kenneth Wester; Anna Sjรถstrรถm; Anders Holmberg; Sten Nilsson; Jรถrgen ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 518 KB

Bladder cancers frequently exhibit an increased number of epidermal growth factor receptors (EGFR) in comparison to normal urothelium. The EGFR could potentially be a target for toxic conjugates. The aim of our study was to compare the expression of EGFR in metastases with concurrent or primary tumo